An E-platform for Learners

Industries

Pharma Industries

Anixa Biosciences Gains Key Patent for CAR-T Cancer Therapy, Secured Until 2045

Anixa Biosciences Gains Key Patent for CAR-T Cancer Therapy, Secured Until 2045

Pharm'Up

Anixa Biosciences, a clinical-stage biotech company specializing in cancer treatment, has announced the issuance of a new...

Valneva’s Chikungunya Vaccine IXCHIQ® Now Approved for Use in Individuals 60 and Older

Valneva’s Chikungunya Vaccine IXCHIQ® Now Approved for Use in Individuals 60 and Older

Pharm'Up

Valneva SE announced that the U.S. Food and Drug Administration (FDA) has lifted its recommended pause on...

Tackling the Obesity Epidemic: New Medications and Pharmacist-Led Strategies for Enhanced Cardiovascular Health

Tackling the Obesity Epidemic: New Medications and Pharmacist-Led Strategies for Enhanced Cardiovascular Health

Pharm'Up

The global fight against obesity is at a critical turning point, with new pharmacological innovations and evolving...

Hidden Dangers: Pharmacists at the Forefront of Managing Drug-Herb Interactions in Cancer Patients

Hidden Dangers: Pharmacists at the Forefront of Managing Drug-Herb Interactions in Cancer Patients

Pharm'Up

A significant and often-overlooked threat to the safety and efficacy of cancer treatment lies in the common...

New Vaccine Shows Promise Against Pneumonia in Older Adults

New Vaccine Shows Promise Against Pneumonia in Older Adults

Pharm'Up

A recent prospective surveillance study published in the Journal of the American Medical Association has shed light...

Indian Pharma Braces for Potential US Tariffs with Strategic Countermeasures

Indian Pharma Braces for Potential US Tariffs with Strategic Countermeasures

Pharm'Up

India’s pharmaceutical industry is proactively developing a multi-pronged strategy to protect itself from potential tariff shocks, as...

FDA Mandates Opioid Label Changes to Emphasize Long-Term Risk

FDA Mandates Opioid Label Changes to Emphasize Long-Term Risk

Pharm'Up

In a significant move to combat the opioid crisis, the FDA has mandated sweeping changes to the...

FDA Proposes Crackdown on Synthetic Kratom Derivative, Citing Opioid-Like Dangers

FDA Proposes Crackdown on Synthetic Kratom Derivative, Citing Opioid-Like Dangers

Pharm'Up

In a critical move to combat a potential new front in the opioid crisis, the FDA has...

Breakthrough Treatment for a Rare Brain Cancer Receives FDA Approval

Breakthrough Treatment for a Rare Brain Cancer Receives FDA Approval

Pharm'Up

In a significant development for patients with a devastating and rare brain cancer, the U.S. Food and...

Analyzing the “Big, Beautiful Bill”: How OBBBA is Set to Reshape the Health Care Marketplace

Analyzing the “Big, Beautiful Bill”: How OBBBA is Set to Reshape the Health Care Marketplace

Pharm'Up

The One Big Beautiful Bill Act (OBBBA), signed by President Donald J. Trump in July 2025, contains...